Back to Companies
Replimune Group, Inc.
REPLNasdaqCIK: 0001737953
Over the 32 most recent insider filings, Replimune Group, Inc. (REPL) has seen activity from 14 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $1.5M sold, net sales of $1.5M. Patel Sushil (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $2.9M by Patel Sushil. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$10.1M
Purchases
$0
Sales
$1.5M
Unique Insiders
14
Recent Insider Trades
32 loaded
| Aug 11 | REPL Replimune Group, Inc. | BAKER BROS. ADVISORS LP | Insider | Other | $274 |
| Aug 12 | REPL Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Officer | Sell | $148.5K |
| Aug 12 | REPL Replimune Group, Inc. | Schwendenman Andrew | Chief Accounting Officer | Sell | $99.0K |
| Aug 12 | REPL Replimune Group, Inc. | Hill Emily Luisa | Chief Financial Officer | Sell | $148.5K |
| Aug 12 | REPL Replimune Group, Inc. | Patel Sushil | Chief Executive Officer, Director | Sell | $510.3K |
| Jun 3 | REPL Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Officer | Sell | $110.9K |
| May 20 | REPL Replimune Group, Inc. | Patel Sushil | Chief Executive Officer, Director | Sell | $189.6K |
| May 20 | REPL Replimune Group, Inc. | Hill Emily Luisa | Chief Financial Officer | Sell | $39.7K |
| May 20 | REPL Replimune Group, Inc. | Astley-Sparke Philip | Director | Sell | $89.7K |
| May 20 | REPL Replimune Group, Inc. | Schwendenman Andrew | Chief Accounting Officer | Sell | $40.1K |
| May 20 | REPL Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Officer | Sell | $43.8K |
| Apr 7 | REPL Replimune Group, Inc. | Astley-Sparke Philip | Director | Grant | $570.8K |
| Apr 7 | REPL Replimune Group, Inc. | Dhingra Kapil | Director | Award | $338.6K |
| Apr 7 | REPL Replimune Group, Inc. | Oliger Christy J. | Director | Award | $338.6K |
| Apr 7 | REPL Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Officer | Grant | $570.8K |
| Apr 7 | REPL Replimune Group, Inc. | Pucci Paolo | Director | Award | $338.6K |
| Apr 7 | REPL Replimune Group, Inc. | SLATTERY JOSEPH P | Director | Award | $338.6K |
| Apr 7 | REPL Replimune Group, Inc. | Weinand Dieter | Director | Award | $338.6K |
| Apr 7 | REPL Replimune Group, Inc. | Hill Emily Luisa | Chief Financial Officer | Grant | $570.8K |
| Apr 7 | REPL Replimune Group, Inc. | Patel Sushil | Chief Executive Officer, Director | Grant | $2.9M |
| Apr 7 | REPL Replimune Group, Inc. | Peeples-Dyer Veleka | Director | Award | $338.6K |
| Apr 7 | REPL Replimune Group, Inc. | Schwendenman Andrew | Chief Accounting Officer | Grant | $418.6K |
| Apr 7 | REPL Replimune Group, Inc. | Balachandran Madhavan | Director | Award | $338.6K |
| Apr 7 | REPL Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Officer | Grant | $570.8K |
| Apr 7 | REPL Replimune Group, Inc. | BAKER BROS. ADVISORS LP | Insider | Award | $677.3K |
| Dec 19 | REPL Replimune Group, Inc. | Hill Emily Luisa | Chief Financial Officer | Grant | $0 |
| Dec 19 | REPL Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Officer | Grant | $0 |
| Dec 19 | REPL Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Officer | Grant | $0 |
| Dec 19 | REPL Replimune Group, Inc. | Schwendenman Andrew | Chief Accounting Officer | Grant | $0 |
| Dec 19 | REPL Replimune Group, Inc. | Patel Sushil | Chief Executive Officer, Director | Grant | $0 |
| Nov 19 | REPL Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Officer | Sell | $47.4K |
| Aug 19 | REPL Replimune Group, Inc. | Hill Emily Luisa | Chief Financial Officer | Sell | $49.2K |
32 filings